Auto-inhibition of Arabidopsis thaliana plasma membrane Ca2+-ATPase involves an interaction of the N-terminus with the small cytoplasmic loop  by Luoni, Laura et al.
FEBS Letters 574 (2004) 20–24 FEBS 28736Auto-inhibition of Arabidopsis thaliana plasma membrane Ca2þ-ATPase
involves an interaction of the N-terminus with the small cytoplasmic loopLaura Luoni*, Silvia Meneghelli, Maria Cristina Bonza, Maria Ida DeMichelis
Dipartimento di Biologia ‘‘L. Gorini’’, Universita di Milano, CNR Istituto di Bioﬁsica – Sezione di Milano, via G. Celoria 26, 20133 Milano, Italy
Received 10 June 2004; revised 30 July 2004; accepted 3 August 2004
Available online 11 August 2004
Edited by Peter BrzezinskiAbstract Type IIB Ca2þ-ATPases have a terminal auto-
inhibitory, domain the action of which is suppressed by calmod-
ulin (CaM) binding. Here, we show that a peptide (6His-1M-I116)
corresponding to the ﬁrst 116 aminoacids (aa) of At-ACA8, the
ﬁrst cloned isoform of Arabidopsis thaliana plasma membrane
Ca2þ-ATPase, inhibits the activity of the enzyme deprived of the
N-terminus by controlled trypsin treatment 10-fold more
eﬃciently than a peptide (41I-T63) corresponding only to the
CaM-binding site. A peptide (268E-W348) corresponding to 81 aa
of the small cytoplasmic loop of At-ACA8 binds peptide 6His-
1M-I116 immobilized on Ni–NTA agarose. Peptide 268E-W348
stimulates Ca2þ-ATPase activity. Its eﬀect is not additive with
that of CaM and is suppressed by tryptic cleavage of the N-
terminus. These results provide the ﬁrst functional identiﬁcation
of a site of intramolecular interaction with the terminal auto-
inhibitory domain of type IIB Ca2þ-ATPases.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
Keywords: Ca2þ-ATPase; Plasma membrane; Calmodulin;
Auto-inhibition; Intramolecular interaction; Arabidopsis
thaliana1. Introduction
Calcium extrusion from the cytoplasm to the apoplast of
plant cells is catalyzed by a Ca2þ-ATPase that drives a Hþ/
Ca2þ exchange. Using both the energy of ATP hydrolysis and
that of the electrochemical proton gradient maintained by the
plasma membrane (PM) Hþ-ATPase, it works far from equi-
librium under physiological conditions and the rate of Ca2þ
extrusion can be precisely tuned by regulation of its catalytic
activity [1–4].
The plant PM Ca2þ-ATPase is a P-type ATPase belonging
to the type IIB family characterized by an extended cytosolic
terminal domain containing a calmodulin (CaM)-binding site
[5–10]. Cleavage of the cytosolic terminal domain by con-
trolled proteolysis or by deletion at the gene level generates* Corresponding author. Fax: +39-2-50314815.
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Abbreviations: aa, aminoacids; CaM, calmodulin; PM, plasma mem-
brane; TM, transmembrane domain
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doi:10.1016/j.febslet.2004.08.003a constitutively active enzyme, indicating that it contains an
auto-inhibitory domain [10–15]. These features are similar to
those of animal PM Ca2þ-ATPase (PMCA), in which the
CaM binding site and the auto-inhibitory domain have been
shown to be largely, although not completely, overlapping
[6,7, and references therein]. However, while the regulatory
domain of PMCA is localized in the extended cytosolic C-
terminal of the protein [6,7, and references therein], the
regulatory domain of plant PM Ca2þ-ATPase is localized in
the extended N-terminal domain [8–10], like in type IIB
Ca2þ-ATPases of plant cells endomembrane [9,10, and ref-
erences therein].
Diﬀerent pieces of evidence indicate that the auto-inhibitory
domain of PMCA extends beyond the CaM-binding site
[6,7,16,17]. Synthetic peptides comprising the CaM-binding
domain of an ER (Arabidopsis thaliana isoform At-ACA2) and
a tonoplast (Brassica oleracea isoform BCA1) isoform of plant
type IIB Ca2þ-ATPases inhibit the activity of N-truncated
enzyme [18,19], indicating that also in plants the auto-inhibi-
tory and CaM-binding domains are at least partly overlapping.
However, single point mutations of At-ACA2 downstream the
peptide sequence generate a deregulated enzyme [20], sug-
gesting that the auto-inhibitory domain may extend beyond
the CaM-binding site.
As to the mechanism of auto-inhibition, it remains to be
elucidated for both the animal and the plant enzymes.
Cross-linking of PMCA with a peptide corresponding to the
extended CaM-binding site allowed the identiﬁcation of two
putative sites of intramolecular interaction for the auto-
inhibitory domain within the cytoplasmic head containing the
catalytic domain: one is localized in the small cytoplasmic
loop connecting transmembrane (TM) domains 2 and 3 and
the other in the big cytoplasmic loop connecting TM4 and
TM5 [21,22]. In At-ACA2, mutation of single residues in the
stalk connecting the cytoplasmic head to the TM domain
generated constitutively active enzymes [20]. These results
overall indicate that in the absence of CaM the regulatory
domain of type IIB Ca2þ-ATPases interacts with one or
more sites in the cytoplasmic head hampering the enzyme’s
catalytic activity.
In this work, we have investigated the mechanism of auto-
inhibition of A. thaliana PM Ca2þ-ATPase and we show
that (i) the N-terminus contains an auto-inhibitory domain
which extends beyond the CaM-binding site and (ii) a se-
quence in the small cytoplasmic loop connecting TM2 and
TM3 interacts with the N-terminus, hampering its auto-
inhibitory action.ation of European Biochemical Societies.
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2.1. Plant material and isolation of PM vesicles
PM was puriﬁed from cell suspension cultures of A. thaliana (L.)
ecotype Landsberg by aqueous two-phase partitioning as reported in
[8]. When speciﬁed, PM (1 mgproteinml1) was treated with trypsin
protease as reported in [12].
2.2. Peptide synthesis
Peptides 41I-T63 and 541S-G557 from At-ACA8 (Accession No.
AJ249352) were synthesized by Primm (Milano, Italy). Identity and
purity of the peptides were tested by HPLC and mass spectrometry.
2.3. Constructs and puriﬁcation of peptides
Standard PCRs were used to amplify the ﬁrst 116 aminoacids (aa) at
the N-terminus of At-ACA8 using At-ACA8 full-length cDNA as
template and the following speciﬁc oligonucleotides:
-(S) 50GATCATATGACGAGTCTCTTGAAGTC30
-(AS) 50GATGGATCCTCAAATTCCAAAATCACCAGC30
The 50 end of the S primer contains an NdeI restriction site and that of
the AS primer a BamHI restriction site. This oligonucleotide pair was
used to product His-tagged At-ACA8 N-terminus (6His-1M-I116).
The sequence 268E-W348 of At-ACA8 was ampliﬁed by standard
PCRs using At-ACA8 full-length cDNA as template and the following
speciﬁc oligonucleotides:
-(S) 50GGAGGATCCGAGATTTCGATCTATGAC30
-(AS) 50TCCCCCGGGTCACCATTCAGTGTTGACTCC30
The 50 end of the S primer contains a BamHI restriction site and that of
the AS primer a SmaI restriction site. This oligonucleotide pair was
used to product 268E-W348 of At-ACA8 fused to glutathione S-trans-
ferase (GST-268E-W348).
PCR was performed in a Robocycler Gradient 40 (Stratagene) using
Advantage cDNA Polymerase mix (Clontech) for 25 cycles as follows:
94 C for 90 sec, 58 C (6His-1M-I116) or 65 C (GST-268E-W348) for 1
min and 72 C for 1 min. The PCR products were ﬁrst cloned into the
pCR2.1 vector to ensure the absence of mistakes by sequencing
(Primm Milano, Italy) and then moved into a pET-15b vector (inser-
tion at the NdeI–BamHI sites) or into a pGEX-2TK vector (insertion
at the BamHI–SmaI sites) for construction of 6His-1M-I116 or GST-
268E-W348, respectively. The correct insertion in pET-15b and pGEX-
2TK vectors was ensured by sequencing. Peptides were overexpressed
in Escherichia coli strain BL21 (DE3)p LysS. Cells were grown at 37 C
until an OD600of 0.6 was reached, then isopropyl b-D-thiogalacto-
pyranoside was added (1 mM ﬁnal concentration) and the culture
grown for 2 h. 6His-1M-I116 and GST-268E-W348 were puriﬁed by af-
ﬁnity chromatography. respectively. on Ni–NTA agarose gel (QIA-
GEN Code No. 30210) and Glutathione–Sepharose 4B gel (Amersham
Biosciences Code No. 17–0756–01). The puriﬁcation procedure was
performed under native conditions as described in the manufacturer’s
instructions except for the addition of 0.5% (v/v) Triton X-100 during
cell lysis. 268E-W348 peptide released from GST was obtained by
cleavage of GST-268E-W348 linked to the Glutathione–Sepharose 4B
gel with thrombin protease: after overnight incubation at 4 C with ca.
10 units thrombin per mg of fusion protein, the protease was inacti-
vated by addition of heparin (Sigma Code No. H4784) and anti-
thrombin III (from bovine plasma, Sigma Code No. A9141) in the
ratio of 1.5 units of each per unit of thrombin. 268E-W348 peptide was
collected in the ﬂow through of the column. Protein concentration in
fractions from peptides puriﬁcation procedures was determined using
the Bradford method (Bio-Rad protein assay dye reagent, Code No.
500-0006) and c-globulin as the standard.
2.4. Assays of Ca2þ-ATPase activity
Ca2þ-ATPase hydrolytic activity in native and trypsin-treated PM
(0.1 lg of protein per ll) was measured as Ca2þ-dependent MgITP
hydrolysis as described in [8]. Unless otherwise speciﬁed, free Ca2þ
concentration was buﬀered at 10 lM with 1 mM EGTA. Bovine brain
CaM (Sigma Code No. P2277) was supplied at 1 lM. To test the eﬀect
of diﬀerent peptides, PM proteins were pre-incubated with the speciﬁed
peptide in assay buﬀer for 20 min at 4 C before starting the reaction
by addition of MgITP. Samples were incubated at 25 C for 60 min.
Ca2þ-dependent ATPase activity was determined as the diﬀerence be-
tween the activities measured in the presence and in the absence of
Ca2þ. All the assays were performed at least three times with three
replicates; S.E. did not exceed 5%.2.5. Electrophoresis and immunoblotting analysis
SDS–PAGE, Western blotting and immunodecoration with poly-
clonal antibodies against the portion 17V-T31 of At-ACA8 were per-
formed as described in [8].
Polyclonal antibodies against the sequence 268E-W348 of At-ACA8
were obtained by rabbit inoculation with GST-268E-W348 fusion
protein (see below) and puriﬁed by aﬃnity chromatography on
Glutathione–Sepharose 4B gel. The blot was incubated 2 h at 25 C
with anti-268E-W348 diluted 1:3000 in 3% (w/v) BSA, 0.1% (v/v)
polyoxyethylene(20)sorbitan monolaurate, 0.15 M NaCl and 20 mM
Tris–HCl, pH 7.4. Signal detection was performed with an ECL anti-
rabbit IgG antibody linked to horseradish peroxidase (Amersham
Biosciences Code No. NA934) diluted 1:5000 in the same solution
reported above.
2.6. Binding of 268E-W 348 to gel-bound At-ACA8 N-terminus
Peptide 6His-1M-I116 (ca. 10 nmol) was immobilized onto 350 ll of
Ni–NTA agarose gel as described above and incubated for 90 min at 4
C under gentle rotation with 3.5 nmol of 268E-W348 in 300 ll of 40
mM BTP-HEPES, pH 7, 50 mM KCl, 3 mM MgSO4, 0.1 mM am-
monium molybdate, 5 mM (NH4)2SO4 and 1 lM free Ca2þ (buﬀered
with 1 mM EGTA). After extensive washing with the same solution
described above without peptide 268E-W348, the gel was loaded in a
small Polystyrene column and gel elution was performed with 1.5 ml of
300 mM imidazole in 10 mM Tris, pH 8, and 300 mM NaCl. Aliquots
of 120 ll were collected and subjected to SDS–PAGE.3. Results
3.1. Inhibitory eﬀect of the N-terminus of At-ACA8 on the
activity of the truncated PM Ca2þ-ATPase
We have previously shown [8, Luoni et al., unpublished re-
sults] that the CaM-binding domain of At-ACA8, the ﬁrst PM
Ca2þ-ATPase cloned from A. thaliana [8], is comprised within
the sequence 41I-T63. To check whether the auto-inhibitory
domain is localized within the same sequence, we tested the
ability of a synthetic peptide corresponding to At-ACA8 se-
quence 41I-T63 to inhibit the activity of the truncated enzyme,
in comparison with that of the whole At-ACA8 N-terminus
(peptide 6His-1M-I116). Truncated At-ACA8 was obtained by
controlled proteolysis of PM isolated from A. thaliana cultured
cells: all the sequences obtained by sequencing Ca2þ-ATPase
puriﬁed by CaM-aﬃnity chromatography from the PM of
suspension-cultured A. thaliana cells uniquely matched At-
ACA8 sequence, indicating that At-ACA8 is the most abun-
dant isoform of PM Ca2þ-ATPase in PM isolated from this
material [8]. Fig. 1 (top panel) shows that under the applied
conditions trypsin treatment of the PM generated a 106 kDa
protein, which was recognized by an antiserum against the
small cytoplasmic loop of At-ACA8, but not by an antiserum
generated against a sequence within At-ACA8 N-terminus.
Thus, trypsin eﬀectively cleaves about 17 kDa from the cyto-
solic N-terminus of the protein. Ca2þ-ATPase activity in the
trypsin-treated PM fraction was about 3-fold higher than that
measured in control PM in the absence of CaM and insensitive
to CaM (Fig. 1, bottom panel).
Since it has been shown that the inhibitory eﬀect of peptides
corresponding to parts of the regulatory C-terminus of PMCA
is strongly Ca2þ-sensitive [23], the eﬀect of peptides 41I-T63 and
6His-1M-I116 on the activity of the truncated PM Ca2þ-AT-
Pase was assayed both at 1 and at 10 lM free Ca2þ (Fig. 2).
Both peptides inhibited the activity of the enzyme much more
at 1 than at 10 lM free Ca2þ, but peptide 41I-T63 was about ten
times less eﬃcient than peptide 6His-1M-I116: at 1 lM free
Fig. 3. Identiﬁcation of putative sites of intramolecular interaction of
At-ACA8 N-terminus. (A) and (B) represent the alignment of At-
ACA8 and hPMCA4b regions comprising sequences of hPMCA4b
identiﬁed as sites of intramolecular interaction of the C-terminal auto-
inhibitory domain (underlined). Alignment was performed on the
whole deduced amino acid sequence of At-ACA8 and hPMCA4b;
asterisks mark conserved aa. Sequences of At-ACA8 used to design
peptides 268E-W348 and 541S-G557 are in bold. Bottom panel shows the
predicted topology of At-ACA8; regions corresponding to peptides
268E-W348 (small cytoplasmic loop) and 541S-G557 (large cytoplasmic
loop) are highlighted and labeled A and B, respectively.
Fig. 1. Eﬀect of controlled proteolysis on PM Ca2þ-ATPase. PM
proteins treated with or without trypsin as described in Section 2 were
either subjected to SDS–PAGE on 8% (w/v) polyacrylamide and
blotted (top panel) or assayed for Ca2þ-ATPase activity (bottom pa-
nel). Blots were immunodecorated with antibodies raised against At-
ACA8 (Accession No. AJ249352) sequences 268E-W348 (A) or 17V-T31
(B). All lanes were loaded with the same amount of protein (15 lg);
lane 1: control PM; lane 2: trypsin treated PM. Ca2þ-ATPase activity
was assayed in the presence (gray bars) or absence (open bars) of 1 lM
bovine brain CaM. Results are from one experiment representative of
at least two; S.E. of Ca2þ-ATPase activity is shown.
Fig. 2. Eﬀect of peptides 6His-1M-I116 (circles) and 41I-T63 (triangles),
reproducing the corresponding sequences of At-ACA8, on hydrolytic
activity of N-cleaved Ca2þ-ATPase. Ca2þ-ATPase activity of trypsin-
treated PM was assayed in the presence of 1 (closed symbols) or 10
(open symbols) lM free Ca2þ with the speciﬁed peptide concentra-
tions. Data are expressed as percentage of activity in the absence of
peptides, which was 10 nmol min1 mg1 protein at 1 lM free Ca2þ
and 28 nmol min1 mg1 protein at 10 lM free Ca2þ. Results are from
one experiment representative of four; S.E. did not exceed 5%.
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6His-1M-I116 and 34 lM 41I-T63.
3.2. Identiﬁcation of intramolecular interaction site of the
auto-inhibitory N-terminal domain
The aa sequence of At-ACA8 has about 35% identity with
that of diﬀerent PMCA isoforms [8]. In correspondence of the
sequence in the small cytoplasmic loop identiﬁed as a site of
intramolecular interaction of the regulatory C-terminus of
hPMCA4b [22], aa identity between At-ACA8 and hPMCA4b
is as high as 53% (Fig. 3A). Identity is lower (37%), but simi-
larity is high (Fig. 3B) in correspondence of the other site of
intramolecular interaction of the regulatory C-terminus iden-
tiﬁed in the large cytoplasmic loop of hPMCA4b [21]. To check
whether the mechanism of auto-inhibition of At-ACA8 is
similar to that of PMCA, we designed and produced two
peptides corresponding, respectively, to At-ACA8 sequences
268E-W348 (in the small cytoplasmic loop) and 541S-G557 (in the
large cytoplasmic loop): peptide 541S-G557 was synthesized,
while peptide 268E-W348was expressed in E. coli as a fusion
protein with GST, puriﬁed by aﬃnity chromatography and
released from GST by cleavage with thrombin protease.
The eﬀect of the two peptides on Ca2þ-ATPase activity in
PM puriﬁed from A. thaliana cells is shown in Fig. 4. Peptide
268E-W348 stimulated Ca2þ-ATPase activity in a concentration
dependent manner: maximal stimulation was about 50% and
the eﬀect was semi-saturated by 1 lM 268E-W348. On thecontrary, peptide 541S-G557 was virtually ineﬀective, even when
supplied at 67 lM, in the presence or absence of peptide
268E-W348.
Fig. 4. Eﬀect of peptides 268E-W348 (circles) and 541S-G557 (triangles),
reproducing the corresponding sequences of At-ACA8, on PM Ca2þ-
ATPase activity. Open circles represent the eﬀect of increasing con-
centrations of peptide 268E-W348in the presence of 67 lM 541S-G557.
Results (±S.E.) are from one experiment representative of three.
Fig. 5. Binding of peptide 268E-W348 to peptide 6His-1M-I116. Peptide
6His-1M-I116 was immobilized on Ni–NTA agarose gel (lanes 2 and 4)
as described in Section 2; the gel was loaded with (lane 2) or without
(lane 4) 35 nmol of peptide 268E-W348 and after extensive washing
elution was performed with 300 mM imidazole. As a control, the same
amount of peptide 268E-W348 was loaded on a void Ni–NTA agarose
gel and elution performed as above (lane 3). Lanes 2, 3 and 4 were
loaded with the same volume of imidazole-eluted peak fractions. Lane
1 was loaded with 0.7 nmol of 268E-W348. After SDS–PAGE on 18%
(w/v) polyacrylamide proteins were detected by Coomassie blue
staining. Results are from one experiment representative of two.
Fig. 6. Lack of eﬀect of peptide 268E-W348 on PM Ca2þ-ATPase acti-
vated by CaM or by tryptic cleavage of the N-terminus. Open bars:
control; gray bars: 10 lM 268E-W348; dashed bars: 1 lM bovine brain
CaM; closed bars: 10 lM 268E-W348 plus 1 lM bovine brain CaM.
Results (±S.E.) are from one experiment representative of three.
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minus, a pull-down experiment was performed by incubating a
Ni–NTA agarose gel on which peptide 6His-1M-I116 had been
immobilized with peptide 268E-W348 (Fig. 5). Upon gel elution
with 300 mM imidazole, a peptide with the mass of 268E-W348
co-eluted with 6His-1M-I116 (Fig. 5, lane 2). No peptide of the
same molecular mass was detected in mocks lacking 6His-1M-
I116 (Fig. 5, lane 3) or 268E-W348 (Fig. 5, lane 4).
Fig. 6 shows that the eﬀect of peptide 268E-W348 on Ca2þ-
ATPase activity was not additive with that of CaM, and that
peptide 268E-W348was ineﬀective on enzyme activity in trypsin-
treated PM.4. Discussion
It is well known that type IIB Ca2þ-ATPases have an auto-
inhibitory domain, the action of which is suppressed by CaM
binding. However, while the site of CaM binding has been
deﬁned in some detail both in diﬀerent isoforms of PMCA and
in plant type IIB Ca2þ-ATPases localized at endomembranesor at the PM (for a review see [6,7,9,10]), less is known about
the mechanism of auto-inhibition.
Here, we show that peptide 6His-1M-I116 corresponding to
At-ACA8 N-terminus inhibits enzyme activity in PM subjected
to controlled trypsin treatment, which selectively cleaves ca. 17
kDa from the N-terminal part of the protein. This result in-
dicates that the N-terminus of At-ACA8, similar to the C-
terminus of PMCA [21,22], interacts with one or more sites of
the protein, inhibiting enzyme activity. Peptide 41I-T63, com-
prising At-ACA8 CaM-binding domain, inhibits as well, but
with 10-fold lower eﬃciency. This result indicates that, like in
PMCA and plant endomembrane type IIB Ca2þ-ATPases
[6,7,16,17,20] the auto-inhibitory domain in the N-terminus of
At-ACA8 extends beyond the CaM binding site. Further work
will be necessary to precisely deﬁne the auto-inhibitory site(s)
within At-ACA8 N-terminus.
Themajor output of this work is the ﬁnding that peptide 268E-
W348 corresponding to a sequence of the small cytoplasmic loop
of At-ACA8 binds to peptide 6His-1M-I116 and is able to stim-
ulate PM Ca2þ-ATPase activity. The latter eﬀect is not additive
with that of CaMand is abolished by controlled tryptic cleavage
of At-ACA8, indicating that it results from 268E-W348 interac-
tion with the N-terminus of the enzyme. Peptide 268E-W348
corresponds to one of the sequences identiﬁed in PMCAas a site
of intramolecular interaction of the regulatoryC-terminus of the
protein [22]. This result suggests that despite the diﬀerent lo-
calization of the terminal regulatory domain, plant and animal
type IIB Ca2þ-ATPases share a similar mechanism of auto-
inhibition. In the light of our results, the simplest interpretation
of the eﬀect of single point mutations in the stalk connecting the
small cytoplasmic loop to the transmembrane helices of At-
ACA2 [20] is that they determine a long distance conformational
change that disrupts the docking of the auto-inhibitory domain
with the cytoplasmic head.
The small cytoplasmic loop is part of the actuator domain of
P-type ATPases. Crystallographic analysis of sarcoplasmic
reticulum Ca2þ-ATPase has shown that the actuator domain
moves substantially during the catalytic cycle so that in the E2
conformation the highly conserved sequence TGES, comprised
in the 268E-W348 peptide used in this study, meets the highly
conserved TGD motif in the phosphorylation domain [24].
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ment of the actuator domain, thus inhibiting enzyme activity.
Binding of CaM or of peptide 268E-W348 to the N-terminus
would abolish its intramolecular interaction leading to enzyme
activation.
Peptide 268E-W348 does not stimulate PM Ca2þ-ATPase ac-
tivity as much as CaM, suggesting that binding of 268E-W348
does not suppress the auto-inhibitory action of the N-terminus
as eﬃciently as CaM. Cross-linking of PMCA with a peptide
corresponding to the extended CaM-binding site led to iden-
tiﬁcation of a second site of intramolecular interaction of the
regulatory domain within the nucleotide-binding domain in
the large cytoplasmic loop [21]. Site-directed mutagenesis of
the regulatory C-terminus of plant PM Hþ-ATPase led to the
identiﬁcation of two distinct auto-inhibitory domains, which
diﬀerently aﬀect enzyme activity [25, and references therein]. It
is thus possible that also in At-ACA8 the auto-inhibitory ac-
tion of the N-terminus involves binding of two auto-inhibitory
domains to two sites in the cytoplasmic head and that binding
of peptide 268E-W348 does not suppress N-terminus interaction
with the second site.
The synthetic peptide 541S-G557 reproducing At-ACA8 se-
quence corresponding to the site of intramolecular interaction
of the regulatory C-terminus of PMCA in the large cytoplas-
mic loop [21] did not aﬀect PM Ca2þ-ATPase activity. Further
work is necessary to ascertain whether this result depends on
the small size of the used peptide, or on a diﬀerent localization
of a second site of intramolecular interaction of the regulatory
domain in At-ACA8. Indeed, several single point mutations
within the phosphorylation domain of plant and yeast PM Hþ-
ATPases generated constitutively active enzymes, pointing to
the phosphorylation domain as a possible site of intramolec-
ular interaction of the regulatory C-terminus [25, and refer-
ences therein].
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